GILLIS EDWARD M 4

What Happened
Edward M. Gillis, Senior Vice President, Devices at BioCardia (BCDA), was granted/received 39,521 restricted stock units (RSUs) that vested on June 29, 2026. The filing shows an acquisition value of $1.20 per share, for a total value of $47,425. This was an award/compensation vesting event (code A), not an open-market purchase or sale.

Key Details

• Transaction date: June 29, 2026; Filing date: July 1, 2026 (Accession 0001437749-26-022363).
• Price/value: $1.20 per share; total reported value $47,425.
• Shares involved: 39,521 RSUs vested and converted into the right to receive common shares.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: RSUs represent contingent rights to receive one share each; 100% of these RSUs vested on June 29, 2026 and were awarded as compensation in lieu of cash.
• Filing timeliness: No indication of a late filing in the provided record.

Context
RSU vesting is a compensation event and does not by itself indicate buying or selling sentiment. The award converted to a contingent right to receive shares upon vesting; there is no indication shares were immediately sold. The reported value (~$47k) is modest relative to many executive grants and reflects compensation rather than an open-market investment.